US2007135361A1PendingUtilityA1

Method of diagnosing alzheimer's disease by detection of chlamydia pneumoniae

62
Individually held — no corporate assignee on recordPriority: Jan 9, 1998Filed: Jan 17, 2007Published: Jun 14, 2007
Est. expiryJan 9, 2018(expired)· nominal 20-yr term from priority
Inventors:Brian J. BalinJ. Todd AbramsAlan P. HudsonJudith A. Whittum-Hudson
A61K 31/496G01N 33/6896G01N 2333/295A61K 31/42C07K 2317/77A61K 31/00G01N 2800/2821A61K 31/65A61K 45/06A61K 31/7048A61K 31/7052Y10S436/811A61K 31/706A61K 31/505C07K 16/125A61K 31/5383
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a method of treating Alzheimer's disease in a mammal comprising administering to the mammal an anti-microbial agent having anti- Chlamydia pneumoniae activity. The invention also relates to a method of diagnosing Alzheimer's disease in a mammal comprising measuring the serum anti- Chlamydia pneumoniae antibody titer in a patient suspected of having Alzheimer's disease.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled)  
     
     
         26 . A method of diagnosing Alzheimer's disease in a human patient, said method comprising detecting evidence of the presence of  C. pneumoniae  in an intranasal sample obtained from said patient, wherein when the presence of  C. pneumoniae  in said sample is an indication that said patient has Alzheimer's disease.  
     
     
         27 - 30 . (canceled)

Join the waitlist — get patent alerts

Track US2007135361A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.